Model‐based dose finding under model uncertainty using general parametric models
José Pinheiro, Björn Bornkamp, Ekkehard Glimm et al. · Statistics in Medicine · 2013
The statistical methodology for the design and analysis of clinical Phase II dose-response studies, with related software implementation, is well developed for the case of a normally distributed, homoscedastic response considered for a single timepoint in parallel group study designs. In practice, however, binary, count, or time-to-event endpoints are encountered, typically measured repeatedly over time and sometimes in more complex settings like crossover study designs. In this paper, we develop an overarching methodology to perform efficient multiple comparisons and modeling for dose finding, under uncertainty about the dose-response shape, using general parametric models. The framework described here is quite broad and can be utilized in situations involving for example generalized nonlinear models, linear and nonlinear mixed effects models, Cox proportional hazards models, with the main restriction being that a univariate dose-response relationship is modeled, that is, both dose and response correspond to univariate measurements. In addition to the core framework, we also develop a general purpose methodology to fit dose-response data in a computationally and statistically efficient way. Several examples illustrate the breadth of applicability of the results. For the analyses, we developed the R add-on package DoseFinding, which provides a convenient interface to the general approach adopted here.
Cited by 163 works. doi:10.1002/sim.6052 Open-access PDF
Authors
References
- Simultaneous Inference in General Parametric Models
- Informative Drop-Out in Longitudinal Data Analysis
- Model Selection: An Integral Part of Inference
- Testing the Statistical Certainty of a Response to Increasing Doses of a Drug
- A graphical approach to sequentially rejective multiple test procedures
- Computation of Multivariate Normal and t Probabilities
- Analyzing incomplete longitudinal clinical trial data
- Critical aspects of the Bayesian approach to phase I cancer trials
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
- Mehrdimensionale Varianzanalyse